| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT05974202 rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder |
Recruitment opened |
| 2026-08-04 | NCT05974202 rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder |
Primary endpoint(s) modified |
| 2026-08-04 | NCT07139106 Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal… |
date change Primary completion pushed: 2028-05-01 -> 2028-10-01 |
| 2026-08-04 | NCT07139106 Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal… |
date change Completion pushed: 2028-05-01 -> 2028-10-01 |
| 2026-08-04 | NCT06518941 An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa |
date change Primary completion pushed: 2027-06 -> 2028-06 |
| 2026-08-04 | NCT06518941 An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa |
date change Completion pushed: 2027-12 -> 2028-12 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07715253 Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05208190 | Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial | Schizophrenia | Recruiting |
| NCT06740890 | Exercise and Olanzapine-samidorphan | Schizophenia Disorder | Recruiting |
| NCT07139106 | Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal… | Major Depressive Disorder (MDD) | Not Yet Recruiting |
| Phase 3 | |||
| NCT03345173 | Facilitating Rapid Naltrexone Initiation | Opioid Dependence | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05011266 | Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid… | Opioid-use Disorder | Recruiting |
| Phase 2 | |||
| NCT04084860 | The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking | Alcohol Use Disorder | Recruiting |
| NCT05999240 | Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder | Autism Spectrum Disorder | Recruiting |
| NCT05690503 | Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With… | Post-acute Sequelae of COVID-19 | Active, Not Recruiting |
| NCT05339256 | Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual | Opioid Use Disorder | Not Yet Recruiting |
| NCT06518941 | An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa | Anorexia Nervosa | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04458545 | Clinical Trials of Multivalent Opioid Vaccine Components | Opioid-use Disorder | Recruiting |
| NCT07423546 | A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia | SCHIZOPHRENIA 1 (Disorder) | Recruiting |
| NCT05712707 | Sublingual Dexmedetomidine for Treating Opioid Withdrawal | Opioid Use Disorder | Active, Not Recruiting |
| NCT04589208 | Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1) | Healthy | Active, Not Recruiting |
| Phase 1 | |||
| NCT05401227 | Glutamatergic Mechanisms: Aim2 | Healthy | Recruiting |
| NCT06977308 | A Multimodal Imaging Study of Dopamine in Early Psychosis | Clinical High Risk for Psychosis (CHR) | Not Yet Recruiting |
| NCT07715253 | Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in… | Schizoaffective Disorder | Not Yet Recruiting |
| Not specified | |||
| NCT05477901 | Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil) | Inflammation | Recruiting |
| NCT04810624 | Relapse Prevention and Changing Habits in Anorexia Nervosa | Anorexia Nervosa | Recruiting |
| NCT05541926 | Scaling up e-Connect in Juvenile Probation Settings | Suicide | Recruiting |
| NCT05918835 | Effects of rTMS on Food Choice in Anorexia Nervosa | Anorexia Nervosa | Recruiting |
| NCT07124780 | Helping Adults With Obsessive-Compulsive Disorder Succeed at Work | Obsessive-Compulsive Disorder (OCD) | Recruiting |
| NCT04663724 | Computer - Based Treatment for Social Anxiety Disorder | Social Anxiety Disorder | Recruiting |
| NCT05974202 | rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder | Cocaine Use | Recruiting |
| NCT05416658 | Shared Decision Making for Antipsychotic Medications | Schizophrenia | Not Yet Recruiting |